The effect of remote ischaemic preconditioning on myocardial injury in emergency hip fracture surgery (PIXIE trial): phase II randomised clinical t…
Authors of this article are:
Ekeloef S, Homilius M, Stilling M, Ekeloef P, Koyuncu S, Münster AB, Meyhoff CS, Gundel O, Holst-Knudsen J, Mathiesen O, Gögenur I0.
A summary of the article is shown below:
OBJECTIVE: To investigate whether remote ischaemic preconditioning (RIPC) prevents myocardial injury in patients undergoing hip fracture surgery.DESIGN: Phase II, multicentre, randomised, observer blinded, clinical trial.SETTING: Three Danish university hospitals, 2015-17.PARTICIPANTS: 648 patients with cardiovascular risk factors undergoing hip fracture surgery. 286 patients were assigned to RIPC and 287 were assigned to standard practice (control group).INTERVENTION: The RIPC procedure was initiated before surgery with a tourniquet applied to the upper arm and consisted of four cycles of forearm ischaemia for five minutes followed by reperfusion for five minutes.MAIN OUTCOME MEASURES: The original primary outcome was myocardial injury within four days of surgery, defined as a peak plasma cardiac troponin I concentration of 45 ng/L or more caused by ischaemia. The revised primary outcome was myocardial injury within four days of surgery, defined as a peak plasma cardiac troponin I concentration of 45 ng/L or more or high sensitive troponin I greater than 24 ng/L (the primary outcome was changed owing to availability of testing). Secondary outcomes were peak plasma troponin I and total troponin I release during the first four days after surgery (cardiac and high sensitive troponin I), perioperative myocardial infarction, major adverse cardiovascular events, and all cause mortality within 30 days of surgery, length of postoperative stay, and length of stay in the intensive care unit. Several planned secondary outcomes will be reported elsewhere.RESULTS: 573 of the 648 randomised patients were included in the intention-to-treat analysis (mean age 79 (SD 10) years; 399 (70%) women). The primary outcome occurred in 25 of 168 (15%) patients in the RIPC group and 45 of 158 (28%) in the control group (odds ratio 0.44, 95% confidence interval 0.25 to 0.76; P=0.003). The revised primary outcome occurred in 57 of 286 patients (20%) in the RIPC group and 90 of 287 (31%) in the control group (0.55, 0.37 to 0.80; P=0.002). Myocardial infarction occurred in 10 patients (3%) in the RIPC group and 21 patients (7%) in the control group (0.46, 0.21 to 0.99; P=0.04). Statistical power was insufficient to draw firm conclusions on differences between groups for the other clinical secondary outcomes (major adverse cardiovascular events, 30 day all cause mortality, length of postoperative stay, and length of stay in the intensive care unit).CONCLUSIONS: RIPC reduced the risk of myocardial injury and infarction after emergency hip fracture surgery. It cannot be concluded that RIPC overall prevents major adverse cardiovascular events after surgery. The findings support larger scale clinical trials to assess longer term clinical outcomes and mortality.TRIAL REGISTRATION: ClinicalTrials.gov NCT02344797.Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Check out the article’s website on Pubmed for more information:
[link-preview url=https://www.ncbi.nlm.nih.gov/pubmed/31801725 forceshot=true]
This article is a good source of information and a good way to become familiar with topics such as: Aged; Aged, 80 and over; Emergency Treatment; Female; Fracture Fixation; Heart Injuries; Hip Fractures; Humans; Intention to Treat Analysis; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Postoperative Complications; Single-Blind Method; Time Factors; Treatment Outcome.
NativeFolder: The Only Bacterial Culture Medium for the Expression of Soluble Proteins
-
- Sale!
- Molecular Biology, Research Kits
NativeFolder Bacterial Culture Medium
- Original price was: $795.00.$295.00Current price is: $295.00.
Interference Test Kit for Assay Validation
-
- Sale!
- Interference, Research Kits
Interference Test Kit
- Original price was: $995.00.$495.00Current price is: $495.00.
Rheumatoid Factor Interference Blocker
-
- Sale!
- Antibodies, Interference
Rheumatoid Factor Interference Blocker
- Original price was: $595.00.$395.00Current price is: $395.00.
New Antibodies from MOLECULAR DEPOT
-
- Sale!
- Antibodies
Zebrafish wnt8b Antibody (Center)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
TRIB2 Antibody (N-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
NTN1 Antibody (C-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
NME1 Antibody
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
Parp9 Antibody (C-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
CDK1 Antibody
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
DANRE hoxc11a Antibody (N-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
VDR Antibody (Center)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
ITIH4 Antibody (C-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
-
- Sale!
- Antibodies
SEMA4B Antibody (C-Term)
- Original price was: $1,295.00.$695.00Current price is: $695.00.
New Proteins from MOLECULAR DEPOT
-
- Sale!
- Conjugates, Proteins
Captopril HSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Proteins
PKC-α, Active, GST-tagged from Xanopus sp.
- Original price was: $1,595.00.$795.00Current price is: $795.00.
-
- Sale!
- Conjugates, Proteins
Prilocain BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Conjugates, Proteins
T3 (Triiodothyronine) BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Conjugates, Proteins
Pipemidic Acid BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Proteins
PKD2 Protein, Active (Recombinant Human)
- Original price was: $1,795.00.$895.00Current price is: $895.00.
-
- Sale!
- Conjugates, Proteins
Meropenem BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Conjugates, Proteins
Piperacillin BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
-
- Sale!
- Proteins
Protein A Peroxidase from Staphylococcus aureus/horseradish
- Original price was: $1,195.00.$595.00Current price is: $595.00.
-
- Sale!
- Conjugates, Proteins
Tobramycin BSA Biotin Conjugate
- Original price was: $1,995.00.$995.00Current price is: $995.00.
New Chemicals from MOLECULAR DEPOT
-
- Sale!
- Chemicals, Interference, Lipids
Triglyceride Mix for Interference Testing
- Original price was: $895.00.$395.00Current price is: $395.00.
-
- Sale!
- Chemicals
Microparticle Stabilizer Solution
- Price range: $295.00 through $495.00
-
- Sale!
- Buffers & Solutions, Chemicals
Enzyme Acceptor Stabilization Buffer
- Original price was: $495.00.$250.00Current price is: $250.00.
-
- Sale!
- Buffers & Solutions, Chemicals
Enzyme Donor Stabilization Buffer
- Original price was: $495.00.$250.00Current price is: $250.00.
-
- Sale!
- Chemicals, Conjugates
Progesterone Biotin Conjugate Solution
- Original price was: $995.00.$595.00Current price is: $595.00.
-
- Sale!
- Buffers & Solutions, Chemicals
Microparticle Activation Buffer
- Price range: $395.00 through $695.00
-
- Sale!
- Buffers & Solutions, Chemicals
Microparticle Washing Buffer
- Price range: $395.00 through $695.00
-
- Sale!
- Buffers & Solutions, Chemicals
Microparticle Blocking Buffer
- Price range: $395.00 through $695.00
-
- Sale!
- Buffers & Solutions, Chemicals
Latex Microparticles Anti Aggregation Agent
- Price range: $295.00 through $3,500.00
-
- Sale!
- Chemicals
CPRG (Chlorophenol red-β-D-galactopyranoside)
- Original price was: $850.00.$395.00Current price is: $395.00.






































